CVS PHARMACY INC
Pharmacy · AMHERST, MA
Organization Active NPI 1689773046
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,538 | 5,070 | $428,297 | $418,959 | $418,959 |
| 2023 | 1,848 | 13,088 | $381,547 | $367,000 | $367,000 |
| 2022 | 2,051 | 15,409 | $273,240 | $253,775 | $253,775 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| 90480 | Admn sarscov2 vacc 1 dose | 1,414 | $43 | $43 |
| 91320 | Sarscv2 vac 30mcg trs-suc im | 1,070 | $153 | $153 |
| G0008 | Administration of influenza virus vaccine | 1,013 | $30 | $30 |
| 90662 | Influenza vaccine split virus, preservative free | 631 | $82 | $82 |
| 90653 | Influenza vaccine, inactivated | 333 | $82 | $82 |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | 326 | $143 | $143 |
| G0009 | Administration of pneumococcal vaccine | 108 | $30 | $30 |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 103 | $291 | $291 |
| 90656 | Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 19 | $22 | $22 |
| 91304 | Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5ml dosage, for intramuscular use | 18 | $153 | $153 |
| 90673 | Influenza vaccine, trivalent derived from recombinant dna | 13 | $82 | $82 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Pharmacy | 333600000X | ✓ | 2787 | MA |
| Durable Medical Equipment & Medical Supplies | 332B00000X | — | — | |
| Community/Retail Pharmacy | 3336C0003X | — | — |
Other Pharmacy providers in Massachusetts
- NPI 1568909679
- NPI 1346349701
- NPI 1033722830
- NPI 1598618233
- NPI 1821043027
- NPI 1386350221
- NPI 1912346974
- NPI 1457170524
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.